"New England Cancer Specialists is a physician-owned, patient-centered medical practice, recognized as a leader in cancer patient care, treatment, and research. With nearly half of Maine’s medical oncologists and hematologists on our team, we are the region’s largest oncology group, serving people in need throughout New England."

During the past decade, New England Cancer Specialists conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "New England Cancer Specialists" #1 collaborator was "Astellas Pharma Global Development, Inc." with 1 trials as a collaborator and "Seagen Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "New England Cancer Specialists" are "Urinary Bladder Cancer, Muscle-invasive" (2 trials), "Non-small Cell Lung Cancer (NSCLC)" (1 trials) and "Other Cancer" (1 trials). Many other conditions were trialed in "New England Cancer Specialists" in a lesser frequency.

Most popular intervention types in "New England Cancer Specialists" are "Drug" (3 trials), "Procedure" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Pembrolizumab" (2 trials), "Surgery (radical cystectomy (RC) plus Pelvic Lymph Node Dissection [PLND])" (2 trials), "Atezolizumab" (1 trials), "Cisplatin" (1 trials) and "Durvalumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "New England Cancer Specialists" are 4 trials for "All" genders.

Currently, there are NaN active trials in "New England Cancer Specialists". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in New England Cancer Specialists, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in New England Cancer Specialists, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

New England Cancer Specialists has several departments that took part in Clinical trials: "New England Cancer Specialists" - 43 trials, "Maine Center for Cancer Medicine-Topsham" - 14 trials